APA (7th ed.) Citation

A, K., M, H., K, H., & S, N. (2026). Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes. PharmacoEconomics, 44(3), 279. https://doi.org/10.1007/s40273-025-01568-y

Chicago Style (17th ed.) Citation

A, Killedar, Howell M, Howard K, and Norris S. "Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes." PharmacoEconomics 44, no. 3 (2026): 279. https://doi.org/10.1007/s40273-025-01568-y.

MLA (9th ed.) Citation

A, Killedar, et al. "Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes." PharmacoEconomics, vol. 44, no. 3, 2026, p. 279, https://doi.org/10.1007/s40273-025-01568-y.